JPRN-UMIN000027435已完成未知
A randomized phase 2 study of TS-1 versus CDDP+VNR for adjuvant therapy in patients with non-small cell lung cancer - LOGIK1702
Clinical Research Support Center Kyushu0 个研究点目标入组 2 人开始时间: 2017年5月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with active double cancer (synchronous double cancer and asynchronous double cancer within 5 years of progression-free period. However, the lesions correspondent to carcinoma in situ of uterine cervix curable by topical treatment, resectable gastric cancer/colorectal cancer by endoscope and topically resectable skin cancer other than malignant melanoma are excluded from active double cancer). 2)Patients with anamnesis of drug-induced hypersensitivity. 3)Patients with severe postoperative complications (such as postoperative infection, rapture suture). 4)Patients with severe complications (such as diarrhoea, intestinal paralysis, ileus, uncontrollable diabetes mellitus, heart failure, kidney failure, liver failure). 5)Patients with interstitial pattern recognized as apparent interstitial pneumonia in chest CT. 6)Patients with active infection. 7)Female patients with pregnant or possibly pregnant (will), or nursing. 8)Patients under treatment of type of fluorinated pyrimidine antineoplastic. 9)Patients under treatment of flucytosine. 10)Any other patients who are regarded as unsuitable for this study by the investigators.
研究者
相似试验
进行中（未招募）
2 期
OGIK1702on-small-cell lung cancerJPRN-jRCTs071180010Matsumoto Keitaro110
招募中
不适用
PhaseI/II study of TS-1+CDDP in combination with Radiotherapy with unresectable and locally advanced for biliary tract cancerBiliary tract cancerJPRN-UMIN000007473Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University25
已完成
1 期
A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)JPRN-UMIN000002183OGSG40
进行中（未招募）
2 期
PIT-2Primary lung cancerMediastinal lymph node metastasis, Squamous cell carcinomaJPRN-jRCTs031180403Suzuki Kenji45
已完成
2 期
A phase II trial of induction CDDP plus TS-1 with concurrent radiotherapy followed by surgical resection in patients with resectable stage IIIA-N2 non-small cell lung cancerJPRN-UMIN000018138Gunma University Hospital30